Please see below for a list of search results.
This position statement outlines guidance provided on consent for post-mortem examination and tissue retention.
The GMC provides guidance setting out good practice principles for doctors involved in research.
Under the Human Tissue Act 2004, the HTA is required to license the storage of relevant material for ‘research in connection with disorders, or the functioning, of the human body’.
The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.
Consent underpins the Human Tissue Act (2004) (HT Act). This section explains the consent exemptions from the Act.
The purpose of this policy is to set out the HTA's policy on human tissue xenografts, whether they are relevant material that fall under the licensing framework of the HT Act 2004 and the consent implications.
This policy describes the Human Tissue Authority’s (HTA’s) policy on the sale of human bodies, body parts and tissue.Purpose
The purpose of this policy is to inform stakeholders of the HTA’s position on the sale of human bodies, body parts or tissue.
The definition of relevant material in the Act is:
Section 53: Relevant material:
The HTA has published guidance for hospital and mortuary staff on brain and spinal cord donation (link is external).